Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report

BACKGROUND: Diffuse alveolar bleeding is a potentially life-threatening condition that can be induced by several drugs. Whereas fatal cases have been reported in patients treated for other indications, no report have so far been published in a patient with multiple sclerosis treated with alemtuzumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Myro, Aija Zuleron, Bjerke, Gisle, Zarnovicky, Svetozar, Holmøy, Trygve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245888/
https://www.ncbi.nlm.nih.gov/pubmed/30454022
http://dx.doi.org/10.1186/s40360-018-0267-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245888/
https://www.ncbi.nlm.nih.gov/pubmed/30454022
http://dx.doi.org/10.1186/s40360-018-0267-5

Ejemplares similares